Page last updated: 2024-11-05

trifluoperazine and Carcinoma, Small Cell

trifluoperazine has been researched along with Carcinoma, Small Cell in 2 studies

Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zacharski, LR1
Moritz, TE1
Haakenson, CM1
O'Donnell, JF1
Ballard, HS1
Johnson, GJ1
Ringenberg, QS1
Schilsky, RL1
Spaulding, MB1
Tornyos, K1
Kennedy, MJ1
Shelley, RK1
Daly, PA1

Other Studies

2 other studies available for trifluoperazine and Carcinoma, Small Cell

ArticleYear
Chronic calcium antagonist use in carcinoma of the lung and colon: a retrospective cohort observational study.
    Cancer investigation, 1990, Volume: 8, Issue:5

    Topics: Calcium; Carcinoma, Small Cell; Cohort Studies; Colonic Neoplasms; Diltiazem; Humans; Lung Neoplasms

1990
Potentiation of small cell lung cancer-related SIADH by trifluoperazine.
    European journal of respiratory diseases, 1987, Volume: 71, Issue:5

    Topics: Carcinoma, Small Cell; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middl

1987